CORDIS · 101103924 · HORIZON
REALLOCATE Rethinking the dEsign of streets And pubLic spaces to Leverage the mOdal shift to Climate-friendly Active Transport Everywhere
Coordinator: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE)
Drastic decrease in transport emissions of 55% by 2030 and 90% by 2050 is required for European cities to reach climate neutrality. This is hindered by inconvenient mobility infrastructure, inadequate services and insufficient governance for short-distance travel, negatively impacting active modes’ safety and security. REALLOCATE’s main objective is to pave the way towards climate-neutral, safe, inclusive and smart European cities through integrated and innovative sustainable urban mobility solutions that will address the needs of diverse groups and communities, while rebalancing street space…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
Co-funding: the European Union contributes €12.0M toward a total project budget of €12.7M — a funding rate of 95%, with the remainder covered by the consortium partners. The project runs over approximately 4 years from 2023-05-01 to 2027-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from IE
see all →- MSCA4Ukraine — MSCA4Ukraine101101923 · HORIZON · €35.0M
- WaterLANDS — Water-based solutions for carbon storage, people and wilderness101036484 · H2020 · €23.1M
- INFRACHIP — European Research Infrastructure on Semiconductor Chips101131822 · HORIZON · €14.5M
- PRIMES — PRIMES: Protein interaction machines in oncogenic EGF receptor signalling278568 · FP7 · €12.0M
- NAMDIATREAM — NANOTECHNOLOGICAL TOOLKITS FOR MULTI-MODAL DISEASE DIAGNOSTICS AND TREATMENT MONITORING246479 · FP7 · €12.0M
- BATPROTECT — Learning from Bats: New Strategies to Extend Healthspan and Improve Disease Resistance101118919 · HORIZON · €11.9M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-IA funding scheme.
- What is the EU contribution?
- The European Commission contributes €12.0M toward a total project budget of €12.7M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-MISS-2022-CIT-01.
- Who coordinates the project?
- The project is coordinated by UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE).
- What is the project timeline?
- The project runs from 2023-05-01 to 2027-04-30 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101103924.